TRIAL DATA
Adjuvant chemotherapy benefits occur early, not in late recurrencesA systematic review of phase III randomized controlled trials for gastrointestinal malignancies including colorectal cancer found that recurrence-free survival improvements were driven by early divergences during active chemotherapy, while late recurrences were not influenced by adjuvant therapy. (Journal of Surgical Research)